NCT03180996View on ClinicalTrials.gov

Global Fenestrated Anaconda Clinical STudy

Active, not recruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

March 31, 2022

Study Completion Date

December 31, 2030

Conditions
Abdominal Aortic Aneurysm
Interventions
DEVICE

Vascutek Fenestrated Anaconda™ Custom AAA Stent Graft System

Fenestrated Endovascular Aortic Repair (FEVAR)

Trial Locations (11)

1160

Wilhelminenspital, Vienna

3121

Epworth Richmond Private Hospital, Melbourne

6009

Hollywood Medical Centre, Perth

T1Y 6J4

Peter Lougheed Centre, Calgary

6815 AD

Rijnstate Hospital, Arnhem

7512 EZ

Medisch Spectrum Twente (MST), Enschede

G713 GZ

Universitair Medisch Centrum Groningen (UMCG), Groningen

3435 CM

Antonius Ziekenhuis, Nieuwegein

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

GU16 7UJ

Frimley Park Hospital, Camberley

W2 1NY

Imperial College, St Mary's Hospital, London

All Listed Sponsors
lead

Vascutek Ltd.

INDUSTRY

NCT03180996 - Global Fenestrated Anaconda Clinical STudy | Biotech Hunter | Biotech Hunter